Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Single-arm Phase III Clinical Trial to Evaluate the Efficacy and Safety of NOVOCART® Inject Plus in the Treatment of Cartilage Defects of the Knee

NCT03319797 is registered in ClinicalTrials.gov with Tetec AG as lead sponsor.

NCT NCT03319797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03319797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Single-arm Phase III Clinical Trial to Evaluate the Efficacy and Safety of NOVOCART® Inject Plus in the Treatment of Cartilage Defects of the Knee
Lead sponsor
Tetec AG
Phase
Phase 3
Overall status
Completed
Start date
October 10, 2017
Completion date
February 22, 2024
Enrollment
100 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

cartilage defects of the knee